Main page

 

Director General : Prof. Dr. Abid Azhar

Dr. A. Q. Khan Institute of Biotechnology and Genetic Engineering (KIBGE) is a well-established scientific research institute with state-of-the-art research facilities that enables research scholars to carry out research in modern biological sciences and imparts higher education at University of Karachi.  The institute aims to explore biotechnological applications and genetic engineering aspects of advanced scientific domains for the improvement of human health and a sustainable natural environment. The objectives of the institute are to disseminate hi-tech training using modern technology and to introduce a wide range of innovative research tools which are currently used throughout the international universities. The academic curriculum guarantees biotechnological specialization on wide ranging topics from biostatistics to research communication skills. Other topics include bioinformatics, biosafety and bioethics, cytogenetics, human molecular genetics, tissue culture, next generation and whole genome sequencing, synthetic biology, nanotechnology, etc. The institute offers research in the following four major disciplines:

Agriculture Biotechnology
focuses research on food safety and security issues such as antimicrobial resistance, pesticides and heavy metal contamination in food chain and sustainable crop production using proteomic and genomic approaches.

Environmental Biotechnology
focuses research on developing biopolymeric nanofibers, nano composites, nanohybrid systems using sustainable approaches for controlling environmental pollutant widespread in the environment.

Industrial Biotechnology
focuses research on production of various industrial metabolites including enzymes, antimicrobial peptides/compounds, biopolymers and nanomaterialsunder in-vivo/in-vitro condition using synthetic biology approaches with their complete structural elucidation.

Medical Biotechnology
focuses research on hereditary and acquired disorders prevalent in the community, cancer genomics, cardiovascular complications, metabolic and inflammatory disorders for disease biomarker discovery and validation.